PD-L1 expression
Are We Hitting the Mark With PD-L1 Biomarker Tests?
Denver—Potential hyperprogression and decreased survival in some patients taking checkpoint inhibitors, ...
AUGUST 15, 2018
Support for Biomarkers in Guiding Checkpoint Inhibitor Rx in NSCLC
Chicago—In the first-line treatment of NSCLC, new studies suggest that biomarkers for checkpoint ligand PD-L1 ...
AUGUST 9, 2018
Load more